Lv41
460 积分 2022-06-20 加入
FAS-less allogeneic CAR T cells
3小时前
已完结
CAR-T therapy in solid tumors
6天前
已完结
In vivo CAR T cells move into clinical trials
1个月前
已完结
CAR T cells produced in vivo to treat cardiac injury
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
1个月前
已完结
Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells
3个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
3个月前
已完结
皖公网安备34019202002308
